← Back to Search

CPAP Machine

CPAP for Polycystic Ovary Syndrome

N/A
Waitlist Available
Led By David A Ehrmann, MD
Research Sponsored by University of Chicago
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Clinical diagnosis of PCOS
Obese (BMI of at least 30 kg/m2)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up after treatment (6 weeks)
Awards & highlights

Study Summary

This trial looks at the effects of sleep problems on metabolism and hormones in women with PCOS.

Eligible Conditions
  • Polycystic Ovary Syndrome
  • Obstructive Sleep Apnea

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
You have been diagnosed with PCOS by a doctor.
Select...
You have a body mass index (BMI) of 30 or higher, which means you are overweight.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~after treatment (6 weeks)
This trial's timeline: 3 weeks for screening, Varies for treatment, and after treatment (6 weeks) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Sex steroid levels
Sleep recording/polysomnography
Secondary outcome measures
24-hour hormonal profiles
Frequently sampled IVGTT

Trial Design

3Treatment groups
Experimental Treatment
Group I: 3Experimental Treatment1 Intervention
Randomized to receive CPAP (continuous positive airway pressure) treatment for 6 weeks.
Group II: 1BExperimental Treatment1 Intervention
Randomized to receive depot Lupron for 6 weeks. Then randomized again to receive progesterone plus placebo for another 6 weeks.
Group III: 1AExperimental Treatment1 Intervention
Randomized to receive depot Lupron for 6 weeks. Then randomized again to receive estrogen plus placebo for another 6 weeks.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
CPAP
2013
Completed Phase 3
~5460

Find a Location

Who is running the clinical trial?

University of ChicagoLead Sponsor
995 Previous Clinical Trials
816,588 Total Patients Enrolled
1 Trials studying Polycystic Ovary Syndrome
37 Patients Enrolled for Polycystic Ovary Syndrome
Duke UniversityOTHER
2,351 Previous Clinical Trials
3,409,466 Total Patients Enrolled
1 Trials studying Polycystic Ovary Syndrome
4 Patients Enrolled for Polycystic Ovary Syndrome
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)NIH
1,952 Previous Clinical Trials
2,660,764 Total Patients Enrolled
31 Trials studying Polycystic Ovary Syndrome
5,358 Patients Enrolled for Polycystic Ovary Syndrome

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who qualifies to take part in this experimental program?

"This study's principal goal is to recruit 80 individuals, aged 18-40, who possess sclerocystic ovaries and have a BMI of 30 kg/m2 or greater."

Answered by AI

Is there an ongoing recruiting effort for participation in this trial?

"According to clinicaltrials.gov, this medical examination is not presently procuring patients; the trial was first posted on December 1st 2007 and was recently updated October 15th 2021. Despite its lack of recruitment at this moment in time, there are 1700 other trials that have open enrollment."

Answered by AI
Recent research and studies
~5 spots leftby Mar 2025